Target intelligence / Profile preview

Collagen fiber (subendothelial)

Molecular classification
Other (structural extracellular matrix protein/fiber)
01

Overview

Subendothelial collagen fiber refers to the collagen-based fibrillar structures in the subendothelial connective tissue of blood vessels, primarily exposed to blood when the endothelial barrier is breached[1][4][7]. Collagen fibers in this context are composed mainly of fibrillar collagens (primarily type I and III, with type IV present in the basement membrane)[1][4][5]. They serve as structural elements conferring mechanical stability to the vessel wall and as a critical initiator of hemostasis, providing a surface for platelet adhesion and activation following vascular injury[6][7]. This platelet-collagen interaction, mediated through von Willebrand factor (vWF) and specific platelet receptors (like GPVI), is the principal mechanism by which the subendothelial matrix translates vessel damage into a thrombogenic response[6][7][9]. Although pivotal in vascular disease and hemostasis, "subendothelial collagen fiber" is not itself a receptor, enzyme, or canonical molecular drug target, but rather a structural matrix component whose exposure or modification has profound pathophysiological consequences. Note: "Subendothelial collagen fiber" is not a precisely defined drug target or receptor; it refers to a class of macromolecular structures (collagen fibers) present in a specific anatomic location (subendothelium). Thus, its classification as a "target" is not standard, and most drugs interact with cellular mediators or receptors (e.g., GPVI, vWF) that mediate platelet-collagen interactions, not with collagen fibers directly[6][9]. Therefore, "is_incorrect" is true for use as a canonical drug target.

Other names
Subendothelial collagenSubendothelial collagen fiberVascular collagen fiberCollagen types I, III, IV (context-dependent)
02

Mechanism of action

not directly druggable; involved in platelet activation via interaction with vWF and platelet receptors

03

Biological functions

Hemostasis and thrombogenesis (triggers platelet adhesion and aggregation)Provides vessel wall tensile strengthTissue architecture and mechanical support
04

Disease associations

Cardiovascular disease (thrombosis, atherosclerosis)Bleeding disorders (defective collagen-platelet interaction)
05

Safety considerations

Therapeutic targeting of collagen could disrupt normal hemostasis, causing bleeding or vascular fragility.Pathogenic exposure leads to thrombosis risk after vascular injury or plaque rupture.
06

Interacting drugs

antiplatelet agents

Beyond the preview

Go deeper on Collagen fiber (subendothelial).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen fiber (subendothelial).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call